Recovery
BPC-157 Arginate
Also called PDA, Pentadeca Arginate
per administration
The amounts going around come from sellers and forums, not from any study.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 1.67mg/mL
- Volume per draw
- 0.12mL
- Units to dial
- 12
- Doses per cartridge
- 25
Vial label
Copy this into your label printer.
Published research contexts for BPC-157 Arginate describe 200–500 mcg per administration. Descriptive only, not a recommendation.
No pharmacokinetic data of its own; carried over from BPC-157, which is poorly characterized.
An arginate salt form of BPC-157, marketed as pentadeca arginate. No study covers the salt separately from BPC-157, whose own evidence is preclinical and community-derived, so its figures are carried over here and no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.02× single dose
- Time to steady state
- 20hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- BPC-157 preclinical literatureNo literature covers the arginate salt on its own; see the BPC-157 page for the parent's preclinical sources.